Research Facility

Omaha, Nebraska 68729

2 studies enrolling now · 8 studies all time

What they study most

Advanced Breast Cancer, Carcinoid, Carcinoid Tumor, ER+ Breast Cancer, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, HER2-negative Breast Cancer, Hepatocellular Carcinoma (HCC), Metastatic Breast Cancer, Neuroendocrine Tumors, Osteoporosis

Studies at this site

• Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC — Recruiting now
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC — Running, not enrolling
• Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. — Running, not enrolling
• Bone Microarchitecture in Osteopenic Postmenopausal Women — Stopped early
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis — Completed
• Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate — Completed